Cellulose Or Derivative Patents (Class 514/57)
-
Publication number: 20110280857Abstract: A sprayable polymeric foam hemostat for both compressible and non-compressible (intracavitary) acute wounds is disclosed. The foam comprises hydrophobically-modified polymers, such as hm-chitosan, or other amphiphilic polymers that anchor themselves within the membrane of cells in the vicinity of the wound. By rapidly expanding upon being released from a canister pressurized with liquefied gas propellant, the foam is able to enter injured body cavities and staunch bleeding. The seal created is strong enough to substantially prevent the loss of blood from these cavities. Hydrophobically-modified polymers inherently prevent microbial infections and are suitable for oxygen transfer required during normal wound metabolism. The amphiphilic polymers form solid gel networks with blood cells to create a physical clotting mechanism that prevent loss of blood.Type: ApplicationFiled: November 15, 2010Publication date: November 17, 2011Inventors: Matthew Dowling, Srinivasa Raghavan
-
Publication number: 20110274742Abstract: The present invention relates to hydrogel or scaffold compositions and methods of use for cell growth and/or regenerative medicine. The hydrogel comprises a water soluble cellulose compound and, in certain aspects, a fibrous or filamentous matrix. The hydrogels as described provide a support or scaffold that promotes, facilitates, and/or enhances progenitor or stem cell growth and/or differentiation. In addition, the hydrogel is useful for tissue, e.g., cartilage, regeneration and repair.Type: ApplicationFiled: April 29, 2011Publication date: November 10, 2011Inventors: Treena Arinzeh, George Collins, Piyush Modak, Ling-Fang Tseng
-
Publication number: 20110269711Abstract: The present invention provides a medicament or food supplement, that when ingested by an individual, forms a gel mass in the individual's stomach, said gel mass consisting essentially of methylcellulose and water, as well as methods for inducing satiety, reversibly reducing stomach void volume, and reducing caloric intake in an individual.Type: ApplicationFiled: April 27, 2011Publication date: November 3, 2011Inventors: Roland Adden, W. H. Anderson, Britta Huebner, Matthias Knarr
-
Patent number: 8048452Abstract: A pharmaceutical composition comprises a solid amorphous dispersion of a cholesteryl ester transfer protein inhibitor and a concentration-enhancing polymer.Type: GrantFiled: June 2, 2006Date of Patent: November 1, 2011Assignee: Bend Research, Inc.Inventors: William J. Curatolo, Dwayne T. Friesen, Michael J. Gumkowski, Douglas A. Lorenz, James A. S. Nightingale, Roger B. Ruggeri, Ravi M. Shanker
-
Publication number: 20110262521Abstract: The present invention relates to a medical device comprising: a reinforcing member; and bacterial cellulose on at least a portion of the reinforcing member. The invention also relates to a method for making such a medical device.Type: ApplicationFiled: November 6, 2009Publication date: October 27, 2011Applicant: SOFRADIM PRODUCTIONInventors: Yves Bayon, Sébastien Ladet, Olivier Lefranc, Philippe Gravagna
-
Publication number: 20110236447Abstract: The present invention provides an oil-in-water cosmetic excellent in emulsion stability. The oil-in-water cosmetic includes (a) oil-droplet particles consisting of an oil component to be emulsified; (b) vesicle particles for stabilizing the oil-droplet particles; and (c) an aqueous phase containing water and a monohydric aliphatic alcohol having 1 to 4 carbon atoms. It is preferred that the vesicle particles are formed with an amphiphilic substance which spontaneously forms vesicle particles, and that they are localized on surfaces of the oil-droplet particles. It is preferred that the amphiphilic substance be a polyoxyethylene hydrogenated castor oil derivative represented by the following formula (1), wherein E=L+M+N+X+Y+Z, and that said E which represents the average addition mole number of ethylene oxide is 10 to 20.Type: ApplicationFiled: December 3, 2009Publication date: September 29, 2011Applicant: SHISEIDO COMPANY, LTD.Inventors: Masanori Yoshimura, Yuji Matsushita, Takafumi Kurosawa
-
Publication number: 20110236433Abstract: An absorbent wound care device includes two or more materials which individually do not gel when exposed to a fluid but do gel when brought together and exposed to a fluid. The device is particularly intended for haemostatic use and for absorbing bodily fluids being emitted from wounds and physiological target sites.Type: ApplicationFiled: September 14, 2009Publication date: September 29, 2011Applicant: MEDTRADE PRODUCTS LIMITEDInventors: Craig Hardy, Stewart Andrew Darby
-
Patent number: 8026226Abstract: The present invention provides a method for using processed cellulose. Preferably, the processed cellulose is a highly refined cellulose (HRC). The HRC is useful in a number of medical and nutritional applications. These medical and nutritional applications can include, but are not limited to, administering effective amounts of the HRC for lowering values of risk factor measurements for such diseases as arteriosclerotic cardiovascular disease and diabetes. Treatment of other diseases and conditions with the HRC is also possible.Type: GrantFiled: October 11, 2002Date of Patent: September 27, 2011Assignee: Regents of the University of MinnesotaInventors: Paul Bradley Addis, Rongsheng Roger Ruan, Joseph M. Keenan, Daniela Geleva
-
Publication number: 20110230439Abstract: Provided are food products comprising at least 0.5 g of trans fatty acid per serving and at least 1.33 weight percent of one or more water-soluble cellulose derivatives, based on the total weight of the food product, methods of ameliorating the harmful effects of trans fatty acids on a mammal that has consumed trans fatty acids, and methods of reducing the amount of trans fatty acids capable of being absorbed by a mammal ingesting a trans fatty acid containing food product.Type: ApplicationFiled: October 16, 2009Publication date: September 22, 2011Inventors: Kerr Anderson, David R. Albers, Scott A. Young, Wallace H. Yokoyama
-
Publication number: 20110224724Abstract: A hydrogel tissue adhesive formed by reacting an aminated polysaccharide with a water-dispersible, aldehyde-functionalized multi-arm polyether is described. The hydrogel tissue adhesive may be useful as a general tissue adhesive and sealant for medical and veterinary applications such as wound closure, supplementing or replacing sutures or staples in internal surgical procedures such as intestinal anastomosis and vascular anastomosis, tissue repair, ophthalmic procedures, drug delivery, and to prevent post-surgical adhesions. Additionally, due to the presence of the aminated polysaccharide, the hydrogel tissue adhesive may also promote wound healing and blood coagulation, and provide antimicrobial properties.Type: ApplicationFiled: August 31, 2009Publication date: September 15, 2011Inventors: Helen S.M. Lu, Steven Willis Shuey
-
Publication number: 20110224167Abstract: A skin-protecting alkalinity-controlling composition comprises one or more carboxylic acid polysaccharides. Said compositions are capable of providing buffering, and thus avoiding a major increase in the pH of an aqueous system and/or are capable of reducing the pH of aqueous systems, in which alkalinity is formed as a result of chemical and/or biological reactions. The compositions may be used in personal care products, such as skin creams and lotions, hygiene products, wound care products, fabric treating products etc.Type: ApplicationFiled: January 28, 2011Publication date: September 15, 2011Applicant: CP Kelco ApSInventor: Jens Eskil Trudsoe
-
Publication number: 20110217249Abstract: The present invention provides compositions containing one or more antimicrobial peptide sequestering compounds and methods for topical application of such compositions to the skin to treat skin diseases and disorders such as rosacea in humans.Type: ApplicationFiled: March 2, 2011Publication date: September 8, 2011Inventor: Frank Dreher
-
Patent number: 8012460Abstract: The invention relates to cosmetic preparations in the form of gel emulsions on preparations of the O/W emulsion type having a hydrocolloid content. Said hydrocolloids are selected from the group of preparations based on (i) hydroxyethylcellulose, (ii) xanthan gum, (iii) carbomer. Said preparations further contain (iv) one or more lipids, (v) one or more non-ionic and/or anionic emulsifiers with HLB values between 8 and 16, the overall content of the emulsifiers not exceeding 1.5% by weight.Type: GrantFiled: February 13, 2002Date of Patent: September 6, 2011Assignee: Beiersdorf AGInventors: Chemals Füller Kohlhase, Stefanie Von Thaden, Andreas Bleckmann, Christel Lemm, Detlef Emeis
-
Publication number: 20110212044Abstract: There is provided a detergent composition that exhibits excellent conditioning performance, the hair detergent composition including an anionic surfactant and a silane-modified cationized cellulose, wherein the anionic surfactant is preferably a polyoxyethylene alkyl ether sulfate. Also provided is a skin detergent composition including an anionic surfactant and a silane-modified cationized cellulose.Type: ApplicationFiled: May 10, 2011Publication date: September 1, 2011Applicant: LION CORPORATIONInventors: Youichirou Kohno, Nobuyasu Sato, Yoko Osako, Miho Tanabe, Yoshifumi Yamagata
-
Publication number: 20110200670Abstract: The present invention relates to soft pastilles for nicotine replacement therapy, said pastille comprises about 0.05% to about 1% of nicotine active; about 5% to about 40% of gelling agent; about 30% to about 70% of plasticizer; about 0.05% to about 10% of sweetener; 0.5% to about 30% of releasing agent; about 0.05% to about 2% of preservative; about 0.01% to 5% of flavouring agent; and about 5% to about 20% of water.Type: ApplicationFiled: February 17, 2011Publication date: August 18, 2011Inventor: Jatin Thakkar
-
Publication number: 20110182987Abstract: This invention relates to a pharmaceutical dosage form for the site specific delivery of more than one active pharmaceutical ingredient to different sites in the human or animal body in the gastrointestinal tract. The dosage form has an outer polymeric layer incorporating a first active pharmaceutical ingredient which reacts to stimuli specific in the stomach, degrades, and releases the first active pharmaceutical ingredient in the stomach for absorption. The dosage form also has at least one inner polymeric layer incorporating a second active pharmaceutical ingredient which, once the outer layer has degraded, passes into the intestine where the polymers of the second layer degrade to release the second active pharmaceutical ingredient. The dosage form may have additional layers each incorporating active pharmaceutical ingredients for release in different portions of the intestine depending on the nature of the polymers.Type: ApplicationFiled: June 3, 2009Publication date: July 28, 2011Inventors: Priya Bawa, Viness Pillay, Yahya Choonara
-
Publication number: 20110182957Abstract: This invention relates to biomaterial compositions, methods and kits for producing hydrogels with tunable physico-chemical properties. Specifically, the invention relates to producing cellulosic hydrogels having optimized physico-chemical properties enabling support of cell growth or as replacement or filler for tissue repair, reconstruction or augmentation.Type: ApplicationFiled: June 19, 2009Publication date: July 28, 2011Inventors: Steven B. Nicoll, Simone S. Stalling, Anna T. Reza
-
Patent number: 7985742Abstract: A multi-component synergistic absorbent composition includes at least one polysaccharide and at least one or more polysaccharide-based components or gelling proteins. This composition possesses synergistic effects in its capacity to absorb water, saline solutions and biological fluids, at normal pressure or under load, or to retain these fluids, or a combination of these properties.Type: GrantFiled: April 24, 2003Date of Patent: July 26, 2011Assignee: Archer Daniels Midland CompanyInventor: David Bergeron
-
Publication number: 20110177143Abstract: Abstract Provided is an oil-based cosmetic preparation which retains a smooth feel. Provided is an oil-based cosmetic preparation containing the following components (A), (B), and (C): (A) a cellulose derivative having a cellulose skeleton in a main chain, in which 67 mol % or more in total hydroxyl groups are substituted with a group —O-M-R, wherein M represents CH2 or a carbonyl group C?O, and R represents a straight or branched alkyl or alkenyl group having 3 to 40 carbon atoms; (B) an ester oil which is liquid at 25° C.; and (C) a hydrocarbon oil which is liquid at 25° C., in which a weight ratio (B)/(C) of the component (B) to the component (C) is 8/1 to 1/4.Type: ApplicationFiled: September 24, 2009Publication date: July 21, 2011Applicant: KAO CorporationInventors: Eiko Tamura, Kouji Ohsaki, Kazuo Kuwahara, Kazuhiro Ishikawa, Kenko Kurita, Yu Saito
-
Publication number: 20110166101Abstract: A substantially porous, micro-particle comprising therapeutically effective amounts of tretinoin and ethyl celluloseType: ApplicationFiled: August 26, 2009Publication date: July 7, 2011Applicant: SUN PHARMA ADVANCED RESEARCH COMPANY LIMITEDInventors: Subhas Balaram Bhowmick, Lalatendu Panigrahi, Sujit Kumar Dolai
-
Publication number: 20110159091Abstract: A tablet for insertion into a vagina including 0.01 to 500 mg of a vaginal medication, such as a microbicide, such as cellulose acetate 1,2-benzenedicarboxylate (CAP); 100 to 500 mg of mannitol powder; 50 to 300 mg of inert microcrystalline cellulose; 10 to 80 mg of hydroxypropyl methylcellulose; 50 to 250 mg of glycerol and optionally 2 to 4 mg of at least one preservative which protects against microbicidal contamination and discourages the growth of yeast in the vagina. The tablet which includes CAP as the vaginal medication is vaginally administered before coitus in methods for preventing the sexual transmission of HIV-1, HIV-2, herpesvirus, or an infection caused by Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis, Haemophilus ducreyi or Treponema pallidum. The tablet which includes CAP as the vaginal medication is vaginally administered to prevent or treat bacterial vaginosis.Type: ApplicationFiled: May 23, 2008Publication date: June 30, 2011Inventors: Alan Stone, Alexander Robert Neurath, Nathan Strick
-
Patent number: 7964218Abstract: The present invention provides an oral grain preparation comprising an agent swellable in the mouth as an active component, wherein the preparation has an inner coating layer of a water-soluble cellulose polymer and an outer coating layer of an ethylcellulose on a plain grain having a diameter of 3 to 4 mm. The agent of the present invention is free from sliminess peculiar to cellulose and adherence of each grains in the mouth at taking, and has excellent feeling for taking without an unpleasant feeling such as caused by a large tablet.Type: GrantFiled: September 5, 2001Date of Patent: June 21, 2011Assignee: Mitsubishi Tanabe Pharma CorporationInventor: Tatsuo Nomura
-
Publication number: 20110142941Abstract: Disclosed are methods of treating subjects having conditions related to angiogenesis including administering an effective amount of a polymeric Nanoparticle form of thyroid hormone agonist, partial agonist or an antagonist thereof, to promote or inhibit angiogenesis in the subject. Compositions of the polymeric forms of thyroid hormone, or thyroid hormone analogs, are also disclosed.Type: ApplicationFiled: November 16, 2010Publication date: June 16, 2011Inventors: Paul J. Davis, Shaker A. Mousa
-
Publication number: 20110130360Abstract: A water-insoluble cellulose derivative, such as ethyl cellulose is useful for preventing or reducing oxidative stress or oxidative cell injury in tissues of an animal and in particular for influencing the level Stearoyl-CoA Desaturase-1 (SCD1) gene expression or ATP synthase mitochondrial F1 complex assembly factor 1 (ATPAF1) gene expression in non-adipose tissues of the animal.Type: ApplicationFiled: October 18, 2007Publication date: June 2, 2011Applicants: DOW GLOBAL TECHNOLOGIES INC., UNITED STATES DEPARTMENT OF AGRICULTUREInventors: Stephanie K. Lynch, Wallace H. Yokoyama, Maciej Turowski
-
Publication number: 20110129515Abstract: The present invention is directed to a nerve regeneration conduit including a resorbable tube having a matrix therein. The matrix is characterized by substantially parallel, axially aligned pores extending the length of the matrix. The matrix is formed by the axial freezing of a slurry having little or no significant radial thermal gradient during the freezing process. The matrix is used to bridge the gap between the severed ends of a nerve and provide a scaffold for nerve regeneration.Type: ApplicationFiled: May 21, 2010Publication date: June 2, 2011Applicant: Integra LifeSciences CorporationInventor: Simon J. Archibald
-
Publication number: 20110126767Abstract: The invention relates to a method for hatching of hatchery eggs comprising: (a) treating the egg shell surface with a coating composition comprising a coating agent, to form a coating on the surface of the egg's shell; and (b) incubating the egg under conditions to cause hatching to occur; wherein the yield of hatching of said hatchery eggs is improved as compared to control eggs not treated as defined in (a). The invention additionally relates to a composition for treating of hatchery eggs prior to incubation, wherein said composition comprising a coating agent, and wherein said composition improves the hatching yield of said hatchery eggs.Type: ApplicationFiled: January 10, 2008Publication date: June 2, 2011Applicant: NATRATEC INTERNATIONAL LTD.Inventors: Jacob Lahav, Emil Polyansky, Shaul Naschitz
-
Patent number: 7951936Abstract: A process for producing a polysaccharide sponge comprises the steps of (A) freezing a photoreactive polysaccharide solution, and (B) irradiating the frozen photoreactive polysaccharide solution with light to crosslink the photoreactive polysaccharide, thereby obtaining the polysaccharide sponge. The process includes simplified steps requiring no removal of solvent, and has such an advantage that impurities are easily removed therefrom.Type: GrantFiled: October 29, 2007Date of Patent: May 31, 2011Assignee: Seikagaku CorporationInventor: Tomoya Sato
-
Publication number: 20110111035Abstract: The various embodiments provide a composition that provides local control over inflammation. The composition localizes the activities of the cytokine-neutralizing antibodies to the site of inflammation through covalent attachment to hydrophilic matrices. The various embodiments including a hydrophilic polymer, a ligand binding moiety covalently attached to the polymer, and optionally, a cellular adhesion peptide covalently attached to the polymer. The hydrophilic polymer may be a glycosaminoglycan such as hyaluronan. The cellular adhesion peptide may be a linear RGD peptide sequence covalently attached to the polymer. The ligand binding moiety may be a monoclonal antibody covalently attached to the polymer. The antibody may be selected from the group consisting of an anti-IL-1?, an anti-IL-6, an anti-TNF-?, and combinations thereof. The polymer functions as a substrate or matrix for cell migration and tissue regeneration.Type: ApplicationFiled: August 15, 2008Publication date: May 12, 2011Inventors: Newell R. Washburn, Sidi Ahmed Bencherif, Liang Tso Sun
-
Publication number: 20110111012Abstract: Wound dressing assemblies and methods of producing the wound dressing assemblies. The wound dressing assemblies various comprise individual layers of nanomaterials that have been formed according to an electrospinning process. Each of the layers can have different characteristics and qualities. The invention also provides guidance in selecting materials to form a wound dressing assembly, as well as possible adaptations to the electrospinning process to provide different characteristics for particular materials.Type: ApplicationFiled: November 12, 2009Publication date: May 12, 2011Inventors: Clinton B. Pepper, Simon McCarthy, Keith Real, Jess Kimball, Jana Ruzickova, Jana Svobodova, Lucia Silovska, Jitka Vankova, Jiri Machat, Radim Dvorak
-
Publication number: 20110104197Abstract: A method for capturing airborne agents or products of agents, such as microorganisms, including viruses, and microbial antigens, toxins and allergens, comprising the formation of at least one curtain of charged particles in the form of an emulsion, a suspension or an aerosol, constantly renewing and regenerating said at least one curtain, and passing air containing airborne agents through said at least one curtain, which acting as a filter captures said agents; as well as a particle formulation for performing the method, comprising any charged particles dispersed in a liquid, including lipid-containing particles, e.g. in the form of an emulsion, or micelles, or lipid-containing particles in the form of an aerosol, or any other charged airborne particles in an aerosol.Type: ApplicationFiled: July 13, 2009Publication date: May 5, 2011Inventors: Bror Morein, Göran Friman, Nils-Gunnar Ilbäck
-
Patent number: 7928087Abstract: The invention concerns novel cosmetic compositions comprising in a cosmetically acceptable medium, at least a fructan, at least a cationic polymer. Said composition provides a flow texture to cosmetic compositions, said compositions are easily rinsed. Hair treated with said composition have a soft feel free of residue. Said compositions are used for washing and/or conditioning keratinous matter such as hair or skin.Type: GrantFiled: January 11, 2002Date of Patent: April 19, 2011Assignee: L'OrealInventors: Géraldine Fack, Chrystel Pourille-Grethen, Serge Restle
-
Patent number: 7919614Abstract: Synthetic polysaccharides are disclosed containing 8-24 monosaccharide units made up of a concatenation of disaccharides consisting of a uronic acid and a hexose, wherein the hydroxyl groups of the polysaccharides are etherified with a C1-6 alkyl group or esterified in the form of a sulpho group, each disaccharide being at least monoetherified; and salts thereof, are disclosed.Type: GrantFiled: October 2, 2003Date of Patent: April 5, 2011Assignees: Sanofi-Aventis, Azko NobelInventors: Philippe Duchaussoy, Jean Marc Herbert, Guy Jaurand, Maurice Petitou, Constant Van Boeckel
-
Patent number: 7919480Abstract: An antimicrobial composition comprising: a complex of a polysaccharide covalently bonded with an antibiotic. A medical device having an antimicrobial composition comprising: a complex of an oxidized regenerated cellulose covalently bonded with gentamicin.Type: GrantFiled: May 3, 2007Date of Patent: April 5, 2011Assignee: Ethicon, Inc.Inventors: Hongbo Liu, Xintian Ming
-
Publication number: 20110076243Abstract: Disclosed are hydrophilic polymers such as polysaccharides, including hyaluronic acid of any origin, modified by reaction with epoxy-functional-silicones. Hydrophobic silicon, which contains chemically active groups covalently attach to the backbone of the hydrophilic polymer and gives these new, modified polymers the ability to dissolve hydrophobic compounds including oils, drugs, and vitamins, while maintaining the hydrophilic properties and benefits of the unmodified polymer. With respect to topical applications these polymers substantially increase the stability of formulations and provide for ease of preparation. The properties and advantages of the original polymer are maintained while other properties are augmented, namely the ability to combine with or dissolve hydrophobic and hydrophilic drugs. The products can be used alone or in combination with other substances for various applications including cosmetic, medical, and drug delivery applications. Also disclosed are methods for preparing them.Type: ApplicationFiled: September 28, 2009Publication date: March 31, 2011Inventors: Adelya K. Leshchiner, Nancy E. Larsen, Edward G. Parent
-
Publication number: 20110071107Abstract: Water-soluble cellulose derivatives are useful in methods of preventing or treating metabolic syndrome or a symptom or condition associated with the metabolic syndrome in an individual, and in particular for preventing or treating one or more of the symptoms a) hypertension, b) proinflammatory or inflammation state and c) prothrombotic state.Type: ApplicationFiled: October 18, 2007Publication date: March 24, 2011Inventors: Stephanie K Lynch, Maciej Turowski, Wallace Yokoyama, Yun-Jeong Hong, Jerry R. Conklin, Shao-Ching Hung, Scott A. Young
-
Patent number: 7906151Abstract: Cosmetic or dermatological composition comprising potassium sorbate and at least one stabilizing agent selected from microcrystalline cellulose, talc and a lipid having an interfacial tension of at least about 10 mN/m.Type: GrantFiled: June 10, 2004Date of Patent: March 15, 2011Assignee: Beiersdorf AGInventors: Rainer Kröpke, Astrid Heptner, Stephanie Von Der Fecht, Jens Nielsen, Celina Storbeck
-
Patent number: 7902173Abstract: The present invention provides a compound selected from sulfated cellulose and salts thereof which can be used as an active ingredient for a cutaneous external preparation produced intending to prevent, soften, improve or cure atopic cutaneous symptoms and the like and which are excellent in a hydrolytic resistance, and dermatitis therapeutic agents and cosmetics using the same.Type: GrantFiled: February 28, 2006Date of Patent: March 8, 2011Assignees: Chisso Corporation, Chisso Petrochemical CorporationInventors: Naoyuki Yoshida, Kazushi Ishida, Shuji Sasaki, Takuo Ikeda, Jun Hiraki, Shigeyuki Aoyama
-
Publication number: 20110053888Abstract: The present invention is related to a new mixture of carbohydrates and its usage for the preparation of a food product intended for oral or enteral nutrition, particularly for the nutrition of the diabetic patient and in particular for the nutrition of the diabetes type II patient and their associated comorbidity. The carbohydrate mixture of the present invention is formed by type IV or RS IV (modified maltodextrins) resistant starch, maltodextrin of low dextrose equivalent DE=5-8, preferably DE equal to 6, insulin and cellulose and is exempt from fructose.Type: ApplicationFiled: May 7, 2008Publication date: March 3, 2011Applicant: Vegenat S.A.Inventors: Angel Gil Hernandez, Paloma San Roman Pais, Milagros Perez Rodriguez
-
Publication number: 20110045075Abstract: Disclosed herein are a kit and a method for forming a tissue coating that prevents undesired tissue-to-tissue adhesions resulting from trauma, surgery, infection, or other stimulus. The tissue coating is a hydrogel formed by reacting an aminocarboxymethyldextran containing primary amine groups with an oxidized carboxymethylcellulose containing aldehyde groups.Type: ApplicationFiled: June 1, 2009Publication date: February 24, 2011Applicant: E. I. DU PONT DE NEMOURS AND COMPANYInventor: Steven W. Shuey
-
Publication number: 20110034411Abstract: Methods for maintaining or improving the gastrointestinal health of animals susceptible to or suffering from poor gastrointestinal health by administering to the animal a gastrointestinal health maintaining or improving amount of a food composition comprising from about 1 to about 20% carbohydrate; from about 3 to about 10% total dietary fiber, wherein the total dietary fiber contains from about 10 to about 40% soluble fiber and from about 90 to about 60% insoluble fiber; and from about 0.1 to about 10% omega-3 fatty acids; wherein the composition has a digestibility coefficient of at least 80. Generally, the compositions are administered to the animal to prevent or treat diarrhea or to improve stool quality. Further, the compositions may be administered in conjunction with one or more probiotics, prebiotics, anti-gastritis drugs, anti-enteritis drugs, or anti-diarrhea drugs, microbial exopolysaccharides, or combinations thereof to maintain or improve gastrointestinal health.Type: ApplicationFiled: September 1, 2009Publication date: February 10, 2011Inventors: Hui Xu, Dorothy Pauline LaFlamme, Carolyn Jean Cupp
-
INJECTABLE VISCOUS MEDICINAL PREPARATION COMPRISING ETHANOL AND AN X-RAY OPAQUE FAT-SOLUBLE COMPOUND
Publication number: 20110028430Abstract: An injectable medicinal preparation is including ethanol and at least one at least partially X-ray opaque, fat-soluble compound, characterized in that it further comprises an ethanol-soluble compound which, when dissolved, has a viscosity ranging from 10 to 700 cP and preferably from 90 to 350 cP at 25° C., so as to provide an embolizing effect-inducing gel, and, in that the ethanol has a purity ranging from 70 to 99% vol., preferably from 90 to 99% vol., so as to provide a sclerosing effect. The preparation is particularly useful for treating venous malformations such as venous angiomas.Type: ApplicationFiled: September 7, 2010Publication date: February 3, 2011Inventors: Jacques Theron, Anne Dompmartin, Daniel Labbe -
Publication number: 20110027371Abstract: The present invention is directed to nanoparticulate compositions comprising statin such as lovastatin or simvastatin. The statin particles of the composition have an effective average particle size of less than about 2000 nm. In another aspect of this invention, novel combinations of statins and other cholesterol lowering agents are described and methods of using same are taught.Type: ApplicationFiled: March 6, 2006Publication date: February 3, 2011Inventors: Eugene R. Cooper, Douglas Hovey, Greta Cary, Marie Lindner, Elaine Liversidge, Gary G. Liversidge, Tuula Ryde
-
Publication number: 20110015586Abstract: This invention relates in general to a method and device for facilitating hemostasis and wound healing. In particular, the invention relates to the device comprising a polymeric material disposed on a scaffold that facilitates hemostasis and wound healing. Specifically, the invention contemplates the use of such scaffolds in conjunction with a negative pressure device.Type: ApplicationFiled: April 16, 2010Publication date: January 20, 2011Inventors: Dennis P. Orgill, Giorgio Pietramaggiori, Sergio Finkielsztein, John N. Vournakis
-
Patent number: 7868164Abstract: A cellulose ether which has from 4,000 to 10,000 anhydroglucose repeat units and is substituted with (a) on the average from 0.0003 to 0.08 moles, per mole of anhydroglucose unit, of a substituent comprising an alkyl or arylalkyl group having from 8 to 24 carbon atoms and (b) a substituent having the formula II wherein R5, R6 and R7 each independently are —CH3 or —C2H5, R8 is —CH2—CHOH—CH2— or —CH2CH2, Az? is an anion, and z is 1, 2 or 3 is useful in hair and skin care compositions.Type: GrantFiled: May 27, 2004Date of Patent: January 11, 2011Inventors: Russell L. Kreeger, Shuiqin Zhou
-
Publication number: 20110003770Abstract: Methods for reducing chronic pain caused by a disrupted spinal disc are described. In one method, a physiologically acceptable amount of an injectable is injected into the disc. The injectable is obtained from a stock solution comprising chondroitin sulphate, glucosamine HCl, aqueous solution of dextrose; sodium carboxymethylcellulose, and a buffer substance in quantity to bring the pH of the stock solution to a value above about 6.0. Water is also added to dilute the stock solution. The stock solution may further comprise an anesthetic such as bupivicaine.Type: ApplicationFiled: December 21, 2009Publication date: January 6, 2011Inventor: Bjorn C.J. Eek
-
Publication number: 20100331278Abstract: Described are an oral ingestion form comprising cationic hydroxyethylcellulose, and methods of using the same in prevention and treatment of metabolic disorders.Type: ApplicationFiled: May 6, 2010Publication date: December 30, 2010Inventors: W. H. Kerr Anderson, Shao-Ching Hung, William T. Stott, Maciej Turowski, Wallace H. Yokoyama, Scott A. Young
-
Publication number: 20100330012Abstract: The present invention is directed to a cosmetic composition that is moisturizing, hydrating, refreshing and long wearing, and has an unique texture and feel comprising a cellulosic gelling agent, an oil-soluble polar modified polymer, and water.Type: ApplicationFiled: June 29, 2010Publication date: December 30, 2010Applicant: L'Oreal S.A.Inventors: Hy Si Bui, Mohamed Kanji, Susan Halpern
-
Publication number: 20100317573Abstract: The present invention relates to a liquid nutritional composition for paediatric patients comprising beta-galacto-oligosaccharides, fructan, non-digestible alpha-glucan and hemicellulose.Type: ApplicationFiled: December 10, 2008Publication date: December 16, 2010Inventors: Anna Christina Goedhart, Martine Sandra Alles, Katrien Maria Jozefa Van Laere
-
Publication number: 20100311688Abstract: The present invention provides compositions for treating and/or preventing signs and symptoms associated with dry eye and/or ocular irritation, and methods of use thereof. Such compositions are provided in novel ophthalmic formulations that are comfortable upon instillation in the eye. Methods of manufacture are also provided.Type: ApplicationFiled: June 4, 2010Publication date: December 9, 2010Applicant: Aciex Therapeutics, Inc.Inventors: Matthew J. Chapin, George Minno, Jackie Nice, George W. Ousler, III, Mark B. Abelson
-
Publication number: 20100311687Abstract: Non-crosslinked derivatives of oligo/polysaccharides of formula I, wherein: X is OH, OM, NH—R1, O—R1; M is an alkaline or alkaline-earth metal, transition metal, or cation containing a quaternary nitrogen atom; Y is H or R2; R1: the residue of an oligo/polysaccharide; R2: the residue of a C1-C4 linear chain aliphatic carboxylic acid or citric acid; provided that at least one X is NH—R1 or O—R1, while the other two X are present in acid (OH) or salified form (OM).Type: ApplicationFiled: December 18, 2007Publication date: December 9, 2010Inventors: Marco Bosco, Luca Stucchi, Fabrizio Picotti, Rita Gianni